Cargando…
Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC
INTRODUCTION: Gene rearrangements are frequent oncologic drivers in NSCLC, and many are suitable for treatment with Food and Drug Administration–approved or experimental targeted therapies. We evaluated the accuracy, specimen acceptance profile, and limits of detection of a rapid fusion assay (Idyll...
Autores principales: | Buglioni, Alessia, Caffes, Patricia L., Hessler, Mark G., Mansfield, Aaron S., Lo, Ying-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758522/ https://www.ncbi.nlm.nih.gov/pubmed/36536899 http://dx.doi.org/10.1016/j.jtocrr.2022.100434 |
Ejemplares similares
-
When ultrarapid is ultrarapid: on importance of temporal precision in neuroscience of language
por: Shtyrov, Yury Y., et al.
Publicado: (2015) -
Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020) -
Validation of an automated assay for measurement of bovine plasma ceruloplasmin
por: Hussein, Hussein Awad, et al.
Publicado: (2019) -
Ultrarapid Opioid Detoxification: Current Status in Iran and Controversies
por: Yassini Ardekani, Seyyed Mojtaba, et al.
Publicado: (2013) -
Microfabricated Ultrarapid Desalting Device for Nanoelectrospray Ionization
Mass Spectrometry
por: Tibavinsky, Ivan A., et al.
Publicado: (2014)